|
1
|
Terasaki M, Hirose A, Narayan B, Baba Y,
Kawagoe C, Yasui H, Saga N, Hosokawa M and Miyashita K: Evaluation
of recoverable functional lipid components of several brown
seaweeds (phaeophyta) from Japan with special reference to
fucoxanthin and fucosterol contents. J Phycol. 45:974–980. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Terasaki M, Narayan B, Kamogawa H, Nomura
M, Stephen NM, Kawagoe C, Hosokawa M and Miyashita K: Carotenoid
profile of edible Japanese seaweeds: An improved HPLC method for
separation of major carotenoids. J Aquat Food Prod Technol.
21:468–479. 2012. View Article : Google Scholar
|
|
3
|
Beppu F, Niwano Y, Tsukui T, Hosokawa M
and Miyashita K: Single and repeated oral dose toxicity study of
fucoxanthin (FX), a marine carotenoid, in mice. J Toxicol Sci.
34:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iio K, Okada Y and Ishikura M: Single and
13-week oral toxicity study of fucoxanthin oil from microalgae in
rats. Shokuhin Eiseigaku Zasshi. 52:183–189. 2011.(In Japanese).
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okuzumi J, Takahashi T, Yamane T, Kitao Y,
Inagake M, Ohya K, Nishino H and Tanaka Y: Inhibitory effects of
fucoxanthin, a natural carotenoid, on
N-ethyl-N'-nitro-N-nitrosoguanidine-induced
mouse duodenal carcinogenesis. Cancer Lett. 68:159–168. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JM, Araki S, Kim DJ, Park CB, Takasuka
N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, et al:
Chemopreventive effects of carotenoids and curcumins on mouse colon
carcinogenesis after 1,2-dimethylhydrazine initiation.
Carcinogenesis. 19:81–85. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishino H: Cancer prevention by
carotenoids. Mutat Res. 402:159–163. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiratori K, Ohgami K, Ilieva I, Jin XH,
Koyama Y, Miyashita K, Yoshida K, Kase S and Ohno S: Effects of
fucoxanthin on lipopolysaccharide-induced inflammation in vitro and
in vivo. Exp Eye Res. 81:422–428. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishikawa S, Hosokawa M and Miyashita K:
Fucoxanthin promotes translocation and induction of glucose
transporter 4 in skeletal muscles of diabetic/obese
KK-Ay mice. Phytomedicine. 19:389–394. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maeda H, Hosokawa M, Sashima T, Funayama K
and Miyashita K: Fucoxanthin from edible seaweed, Undaria
pinnatifida, shows antiobesity effect through UCP1 expression
in white adipose tissues. Biochem Biophys Res Commun. 332:392–397.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hitoe S and Shimoda H: Seaweed fucoxanthin
supplementation improves obesity parameters in mildly obese
Japanese subjects. Funct Food Health Dis. 7:246–262. 2017.
|
|
12
|
Hosokawa M, Kudo M, Maeda H, Kohno H,
Tanaka T and Miyashita K: Fucoxanthin induces apoptosis and
enhances the antiproliferative effect of the PPARgamma ligand,
troglitazone, on colon cancer cells. Biochim Biophys Acta.
1675:113–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Das SK, Hashimoto T and Kanazawa K: Growth
inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is
associated with down-regulation of cyclin D. Biochim Biophys Acta.
1780:743–749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murakami C, Takemura M, Sugiyama Y,
Kamisuki S, Asahara H, Kawasaki M, Ishidoh T, Linn S, Yoshida S,
Sugawara F, et al: Vitamin A-related compounds, all-trans retinal
and retinoic acids, selectively inhibit activities of mammalian
replicative DNA polymerases. Biochim Biophys Acta. 1574:85–92.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okuzumi J, Nishino H, Murakoshi M,
Iwashima A, Tanaka Y, Yamane T, Fujita Y and Takahashi T:
Inhibitory effects of fucoxanthin, a natural carotenoid, on
N-myc expression and cell cycle progression in human
malignant tumor cells. Cancer Lett. 55:75–81. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kotake-Nara E, Terasaki M and Nagao A:
Characterization of apoptosis induced by fucoxanthin in human
promyelocytic leukemia cells. Biosci Biotechnol Biochem.
69:224–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Asai A, Sugawara T, Ono H and Nagao A:
Biotransformation of fucoxanthinol into amarouciaxanthin A in mice
and HepG2 cells: Formation and cytotoxicity of fucoxanthin
metabolites. Drug Metab Dispos. 32:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asai A, Yonekura L and Nagao A: Low
bioavailability of dietary epoxyxanthophylls in humans. Br J Nutr.
100:273–277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hashimoto T, Ozaki Y, Mizuno M, Yoshida M,
Nishitani Y, Azuma T, Komoto A, Maoka T, Tanino Y and Kanazawa K:
Pharmacokinetics of fucoxanthinol in human plasma after the oral
administration of kombu extract. Br J Nutr. 107:1566–1569. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi K, Hosokawa M, Kasajima H,
Hatanaka K, Kudo K, Shimoyama N and Miyashita K: Anticancer effects
of fucoxanthin and fucoxanthinol on colorectal cancer cell lines
and colorectal cancer tissues. Oncol Lett. 10:1463–1467. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vermeulen L, Todaro M, de Sousa Mello F,
Sprick MR, Kemper K, Alea Perez M, Richel DJ, Stassi G and Medema
JP: Single-cell cloning of colon cancer stem cells reveals a
multi-lineage differentiation capacity. Proc Natl Acad Sci USA.
105:13427–13432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanwar SS, Yu Y, Nautiyal J, Patel BB and
Majumdar AP: The Wnt/beta-catenin pathway regulates growth and
maintenance of colonospheres. Mol Cancer. 9:212–225. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Terasaki M, Maeda H, Miyashita K, Tanaka
T, Miyamoto S and Mutoh M: A marine bio-functional lipid,
fucoxanthinol, attenuates human colorectal cancer stem-like cell
tumorigenicity and sphere formation. J Clin Biochem Nutr. 61:25–32.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshida M, Hatano N, Nishiumi S, Irino Y,
Izumi Y, Takenawa T and Azuma T: Diagnosis of gastroenterological
diseases by metabolome analysis using gas chromatography-mass
spectrometry. J Gastroenterol. 47:9–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dazard JE, Sandlers Y, Doerner SK, Berger
NA and Brunengraber H: Metabolomics of ApcMin/+ mice
genetically susceptible to intestinal cancer. BMC Syst Biol.
8:722014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshie T, Nishiumi S, Izumi Y, Sakai A,
Inoue J, Azuma T and Yoshida M: Regulation of the metabolite
profile by an APC gene mutation in colorectal cancer. Cancer Sci.
103:1010–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han XY, Wei B, Fang JF, Zhang S, Zhang FC,
Zhang HB, Lan TY, Lu HQ and Wei HB: Epithelial-mesenchymal
transition associates with maintenance of stemness in
spheroid-derived stem-like colon cancer cells. PLoS One.
8:e733412013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato M, Kawana K, Adachi K, Fujimoto A,
Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Takahashi J,
et al: Spheroid cancer stem cells display reprogrammed metabolism
and obtain energy by actively running the tricarboxylic acid (TCA)
cycle. Oncotarget. 7:33297–33305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vermeersch KA, Wang L, Mezencev R,
McDonald JF and Styczynski MP: OVCAR-3 spheroid-derived cells
display distinct metabolic profiles. PLoS One. 10:e01182622015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Penkert J, Ripperger T, Schieck M,
Schlegelberger B, Steinemann D and Illig T: On metabolic
reprogramming and tumor biology: A comprehensive survey of
metabolism in breast cancer. Oncotarget. 7:67626–67649. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin SH, Liu T, Ming X, Tang Z, Fu L,
Schmitt-Kopplin P, Kanawati B, Guan XY and Cai Z: Regulatory role
of hexosamine biosynthetic pathway on hepatic cancer stem cell
marker CD133 under low glucose conditions. Sci Rep. 6:211842016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen KY, Liu X, Bu P, Lin CS, Rakhilin N,
Locasale JW and Shen X: A metabolic signature of colon cancer
initiating cells. Conf Proc IEEE Eng Med Biol Soc. 2014:4759–4762.
2014.PubMed/NCBI
|
|
37
|
Küntzer J, Eggle D, Lenhof HP, Burtscher H
and Klostermann S: The roche cancer genome database (RCGDB). Hum
Mutat. 31:407–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsuda Y, Miura K, Yamane J, Shima H,
Fujibuchi W, Ishida K, Fujishima F, Ohnuma S, Sasaki H, Nagao M, et
al: SERPINI1 regulates epithelial-mesenchymal transition in an
orthotopic implantation model of colorectal cancer. Cancer Sci.
107:619–628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Russo P, Malacarne D, Falugi C, Trombino S
and O'Connor PM: RPR-115135, a farnesyltransferase inhibitor,
increases 5-FU-cytotoxicity in ten human colon cancer cell lines:
Role of p53. Int J Cancer. 100:266–275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hara K, Hamada C, Wakabayashi K, Kanda R,
Kaneko K, Horikoshi S, Tomino Y and Suzuki Y: Scavenging of
reactive oxygen species by astaxanthin inhibits
epithelial-mesenchymal transition in high glucose-stimulated
mesothelial cells. PLoS One. 12:e01843322017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Festuccia C, Mancini A, Gravina GL,
Scarsella L, Llorens S, Alonso GL, Tatone C, Di Cesare E, Jannini
EA, Lenzi A, et al: Antitumor effects of saffron-derived
carotenoids in prostate cancer cell models. BioMed Res Int.
2014:1350482014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mondul AM, Sampson JN, Moore SC, Weinstein
SJ, Evans AM, Karoly ED, Virtamo J and Albanes D: Metabolomic
profile of response to supplementation with β-carotene in the
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin
Nutr. 98:488–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qin XY, Tatsukawa H, Hitomi K, Shirakami
Y, Ishibashi N, Shimizu M, Moriwaki H and Kojima S: Metabolome
analyses uncovered a novel inhibitory effect of acyclic retinoid on
aberrant lipogenesis in a mouse diethylnitrosamine-induced hepatic
tumorigenesis model. Cancer Prev Res. 9:205–214. 2016. View Article : Google Scholar
|
|
44
|
Huang YT, Lin YW, Chiu HM and Chiang BH:
Curcumin induces apoptosis of colorectal cancer stem cells by
coupling with CD44 marker. J Agric Food Chem. 64:2247–2253. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Amelio I, Cutruzzolá F, Antonov A,
Agostini M and Melino G: Serine and glycine metabolism in cancer.
Trends Biochem Sci. 39:191–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
